Peter Goodhand is a leader in the global health sector as a senior executive and board member in the health research advancement community.
Goodhand played a key role in the creation of the Global Alliance to accelerate progress in genomic research and medicine and in June 2013, he was appointed Executive Director of the Alliance for its critical development phase.
Prior to this role, he was the President and CEO of the Canadian Cancer Society - Canada’s largest health charity. Before joining the charitable sector, Goodhand had a 20 year career in the global medical technology industry, including strategic leadership roles with multinational healthcare companies such as American Cyanamid and Johnson & Johnson and as the founding Managing Director of the Health Technology Exchange (HTX).
He is currently Chair of the Board of HTX; Chair of the Steering Committee of the Occupational Cancer Research Center; Board Member, MaRS EXCITE (Excellence in Clinical Innovation and Technology Evaluation); Executive Committee Member, AGE-WELL Network Centre of Excellence.
Goodhand had a 12-year experience as a patient advocate, caregiver and navigator throughout his family’s battle with a rare cancer.